DXCM Dexcom
8-K Current Report
Filed: February 26, 2026
Health Care
Surgical & Medical Instruments & ApparatusDexcom (DXCM) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items2 items
- Item 5.02: Departure/Election of Directors or Officers
- Item 7.01: Regulation FD Disclosure
AI Filing Analysis8-K
Item 5.02 · Departure/Election of Directors or Officers
- • Board expanded to 12 directors; Rick Osterloh appointed immediately, term through 2026 Annual Meeting
- • Osterloh designated independent; assigned to Compensation Committee and Technology Committee
Item 7.01 · Regulation FD Disclosure
- • Rick Osterloh appointed to Dexcom Board of Directors, effective February 26, 2026
- • Board composition change signals potential strategic direction; Osterloh's background (hardware/consumer tech at Google) relevant to Dexcom's wearable CGM business
Other Dexcom 8-K Filings
Get deeper insights on Dexcom
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.